Atlas Trials

Vaccines, Pneumococcal Conjugate Vaccine

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Vaccines, Pneumococcal Conjugate Vaccine

RecordFirmDate
Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients (NCT00980655)Pfizer2010-01-18
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil (NCT00676091)Wyeth is now a wholly owned subsidiary of Pfizer2008-04-01
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects (NCT00500357)Wyeth is now a wholly owned subsidiary of Pfizer2007-11-01
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants (NCT00574795)Wyeth is now a wholly owned subsidiary of Pfizer2007-09-01
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants (NCT00475033)Wyeth is now a wholly owned subsidiary of Pfizer2007-06-01
Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent) (NCT00683410)Wyeth is now a wholly owned subsidiary of Pfizer2007-04-01
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects (NCT00269672)Wyeth is now a wholly owned subsidiary of Pfizer2005-09-01
Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children (NCT00580684)Wyeth is now a wholly owned subsidiary of Pfizer2003-09-01
Study Evaluating Prevenar Immunogenicity in High Risk Children (NCT00581620)Wyeth is now a wholly owned subsidiary of Pfizer2002-11-01

Track Vaccines, Pneumococcal Conjugate Vaccine automatically

Every clearance here is in the API, with alerts when new ones post.